avapro has been researched along with Aging in 3 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"No statistically significant gender effects were observed in peak plasma concentration (Cmax), area under the curve (AUC), and terminal elimination half-life (t1/2) of irbesartan." | 2.69 | The effects of age and gender on the pharmacokinetics of irbesartan. ( Greene, DS; Shyu, WC; Smith, RA; Vachharajani, NN, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yabumoto, C | 1 |
Akazawa, H | 1 |
Yamamoto, R | 1 |
Yano, M | 1 |
Kudo-Sakamoto, Y | 1 |
Sumida, T | 1 |
Kamo, T | 1 |
Yagi, H | 1 |
Shimizu, Y | 1 |
Saga-Kamo, A | 1 |
Naito, AT | 1 |
Oka, T | 1 |
Lee, JK | 1 |
Suzuki, J | 1 |
Sakata, Y | 1 |
Uejima, E | 1 |
Komuro, I | 1 |
Oudit, GY | 1 |
Kassiri, Z | 1 |
Patel, MP | 1 |
Chappell, M | 1 |
Butany, J | 1 |
Backx, PH | 1 |
Tsushima, RG | 1 |
Scholey, JW | 1 |
Khokha, R | 1 |
Penninger, JM | 1 |
Vachharajani, NN | 1 |
Shyu, WC | 1 |
Smith, RA | 1 |
Greene, DS | 1 |
1 trial available for avapro and Aging
Article | Year |
---|---|
The effects of age and gender on the pharmacokinetics of irbesartan.
Topics: Adolescent; Adult; Aged; Aging; Angiotensin Receptor Antagonists; Antihypertensive Agents; Area Unde | 1998 |
2 other studies available for avapro and Aging
Article | Year |
---|---|
Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.
Topics: Administration, Topical; Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Axin Protein; Biph | 2015 |
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
Topics: Adaptor Proteins, Signal Transducing; Aging; Angiotensin II; Angiotensin-Converting Enzyme 2; Animal | 2007 |